Routine HIV-1 genotyping as a tool to identify dual infections

被引:23
作者
Cornelissen, Marion
Jurriaans, Suzanne
Kozaczynska, Karolina
Prins, Jan M.
Hamidjaja, Raditijo A.
Zorgdrager, Fokla
Bakker, Margreet
Back, Nicole
van der Kuyl, Antoinette C.
机构
[1] Univ Amsterdam, Acad Med Ctr, Lab Expt Virol, Dept Med Microbiol,Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands
关键词
degenerate base codes; drug resistance; dual infection; env sequence analysis; HIV-1; ViroSeq;
D O I
10.1097/QAD.0b013e3280f3c08a
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: The incidence of HIV-1 dual infections is generally thought to be low, but as dual infections have been associated with accelerated disease progression, its recognition is clinically important. Methods to identify HIV-1 dual infections are time consuming and are not routinely performed. Design: Genotyping of the HIV-1 protease and reverse transcriptase (prot/RT) genes is commonly performed in the western world to detect drug-resistance mutations in clinical isolates. In our hospital, prot/RT baseline sequencing is part of the patient care for all newly infected patients in the Amsterdam region since 2003. We reasoned that degenerate base codes in this sequence could indicate either extensive viral evolution or infection with multiple HIV-1 strains. Methods: We amplified, cloned and sequenced multiple HIV-1 envelope (env)-V3 and gag sequences from patients with 34 or more (range 34-99) degenerate base codes in the ViroSeq genotyping RT sequence (37 out of 1661 available records) to estimate the number of HIV-1 dual infections in this group. Results: Of the 37 patients included in this study, 16 (43.2%, equal to 1% of the 1661 total records) had an HIV-1 dual infection based on phylogenetic analysis of env-V3/gag sequences. If only sequences with 45 or more degenerate base codes were taken into account, 73.3% of patients showed evidence of a dual infection. Conclusion: We describe an additional use of routinely performed HIV-1 genotyping. In patients with a high number of degenerate bases (>= 34) in RT it is important to consider the possibility of a dual HIV-1 infection. (c) 2007 Lippincott Williams & Wilkins.
引用
收藏
页码:807 / 811
页数:5
相关论文
共 18 条
[1]   Primary infection of a male plasma donor with divergent HIV variants from the same source followed by rapid fluctuations in their relative frequency and viral recombination [J].
Bernardin, F ;
Herring, BL ;
Peddada, L ;
Delwart, EL .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2003, 19 (11) :1009-1015
[2]  
Chakraborty B, 2004, AIDS RES HUM RETROV, V20, P1026, DOI 10.1089/aid.2004.20.1026
[3]   Evidence for frequent reinfection with human immunodeficiency virus type 1 of a different subtype [J].
Chohan, B ;
Lavreys, L ;
Rainwater, SMJ ;
Overbaugh, J .
JOURNAL OF VIROLOGY, 2005, 79 (16) :10701-10708
[4]   Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes [J].
Cornelissen, M ;
Kampinga, G ;
Zorgdrager, F ;
Goudsmit, J .
JOURNAL OF VIROLOGY, 1996, 70 (11) :8209-8212
[5]   SYNCYTIUM-INDUCING (SI) PHENOTYPE SUPPRESSION AT SEROCONVERSION AFTER INTRAMUSCULAR INOCULATION OF A NON-SYNCYTIUM-INDUCING/SI PHENOTYPICALLY MIXED HUMAN-IMMUNODEFICIENCY-VIRUS POPULATION [J].
CORNELISSEN, M ;
MULDERKAMPINGA, G ;
VEENSTRA, J ;
ZORGDRAGER, F ;
KUIKEN, C ;
HARTMAN, S ;
DEKKER, J ;
VANDERHOEK, L ;
SOL, C ;
COUTINHO, R ;
GOUDSMIT, J .
JOURNAL OF VIROLOGY, 1995, 69 (03) :1810-1818
[6]   HIV-1 superinfection is not a common event [J].
Diaz, RS ;
Pardini, R ;
Catroxo, M ;
Operskalski, EA ;
Mosley, JW ;
Busch, MP .
JOURNAL OF CLINICAL VIROLOGY, 2005, 33 (04) :328-330
[7]   Sensitivity and specificity of the ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for detection of HIV-1 drug resistance mutations by use of an ABI PRISM 3100 genetic analyzer [J].
Eshleman, SH ;
Crutcher, G ;
Petrauskene, O ;
Kunstman, K ;
Cunningham, SP ;
Trevino, C ;
Davis, C ;
Kennedy, J ;
Fairman, J ;
Foley, B ;
Kop, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (02) :813-817
[8]   Recombination following superinfection by HIV-1 [J].
Fang, GW ;
Weiser, B ;
Kuiken, C ;
Philpott, SM ;
Rowland-Jones, S ;
Plummer, F ;
Kimani, J ;
Shi, BS ;
Kaul, R ;
Bwayo, J ;
Anzala, O ;
Burger, H .
AIDS, 2004, 18 (02) :153-159
[9]   HIV-1 superinfections: omens for vaccine efficacy? [J].
Fultz, PN .
AIDS, 2004, 18 (01) :115-119
[10]   In-depth, longitudinal analysis of viral quasispecies from an individual triply infected with late-stage human immunodeficiency virus type 1, using a multiple PCR primer approach [J].
Gerhardt, M ;
Mloka, D ;
Tovanabutra, S ;
Sanders-Buell, E ;
Hoffmann, O ;
Maboko, L ;
Mmbando, D ;
Birx, DL ;
McCutchan, FE ;
Hoelscher, M .
JOURNAL OF VIROLOGY, 2005, 79 (13) :8249-8261